Studying Non Alcoholic Fatty Liver Disease and Liver Fibrosis Among Systemic Lupus Erythematosus Patients at Assiut University Hospital

Study acronym: NAFLD and SLE
StatusUnknown
PhaseNot specified
Started

Record status This record was last updated September 19, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Not Yet Recruiting
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Assiut University
1,667 trials monitored
See 15 trials at risk
NASH / MASH
690 trials monitored
See 23 trials at risk
Lupus (SLE)
667 trials monitored
See 27 trials at risk
Aim of the study :- 1. to estimate prevalence of non alcoholic fatty liver disease and liver fibrosis among Systemic lupus erythematosus patients 2. to determine risk factors in SLE patients contributing to NAFLD and liver fibrosis
Trial Details
NCT Number NCT06601361
Lead Sponsor Assiut University
Conditions
(from sponsor)		 NAFLD - Nonalcoholic Fatty Liver Disease
Related terms Lupus Erythematosus, Systemic, Non-alcoholic Fatty Liver Disease
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov